Ramdas Pharma Distributors Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 02-07-2024
- Paid Up Capital ₹ 2.00 M
as on 02-07-2024
- Company Age 33 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.45 M
as on 02-07-2024
- Revenue -28.56%
(FY 2023)
- Profit -38.81%
(FY 2023)
- Ebitda 18.56%
(FY 2023)
- Net Worth 2.40%
(FY 2023)
- Total Assets 9.92%
(FY 2023)
About Ramdas Pharma Distributors
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹3.45 M.
Ekta Tulsani and Girdhari Tulsani serve as directors at the Company.
- CIN/LLPIN
U51909MH1991PTC060761
- Company No.
060761
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Mar 1991
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ramdas Pharma Distributors?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ekta Tulsani  | Director | 11-May-2012 | Current |
| Girdhari Tulsani | Director | 14-Mar-2007 | Current |
Financial Performance of Ramdas Pharma Distributors.
Ramdas Pharma Distributors Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 28.56% decrease. The company also saw a substantial fall in profitability, with a 38.81% decrease in profit. The company's net worth moved up by a moderate rise of 2.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ramdas Pharma Distributors?
In 2021, Ramdas Pharma Distributors had a promoter holding of 65.00% and a public holding of 35.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ramdas Ventures Private LimitedActive 1 year 4 monthsEkta Tulsani and Girdhari Tulsani are mutual person
- Ramdas Sales India Private LimitedInactive For E-Filing 9 months 23 days
Ekta Tulsani and Girdhari Tulsani are mutual person
- Eg Lifecare Services Private LimitedActive 12 years 4 months
Ekta Tulsani and Girdhari Tulsani are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Saraswat Co-Op. Bank Ltd. Creation Date: 04 Oct 1995 | ₹2.45 M | Open |
The Saraswat Co-Op. Bank Ltd. Creation Date: 06 Oct 1991 | ₹1.00 M | Open |
How Many Employees Work at Ramdas Pharma Distributors?
Unlock and access historical data on people associated with Ramdas Pharma Distributors, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ramdas Pharma Distributors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ramdas Pharma Distributors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
